Personalized Testing - BioReliance Builds a Biologics Clearance Service Facility That’s a Home Away from HomeMarch 11, 2014 | by Mike Auerbach, Editor in Chief @PharmProEditor | Comments
BioReliance, a company that provides testing and manufacturing services to pharmaceutical/biopharma companies, realized that the absence of full featured and customizable biological clearance testing facilities was an opportunity. The company’s recently opened facility in Rockville, MD offers their clients private and secure work lounges along with fully modular lab spaces that can be designed, equipped and ready-to-go upon their arrival.
The movement toward transparency is global, touching almost every aspect of society. Whether the...
The use of disposables in biopharmaceutical production facilities started in the late 1990’s and...
The right combination of equipment, capsule, and formulation can bolster yields, speed up filling, and cut downtime for faster market delivery and higher profits.
The Norwich Pharma Services manufacturing facility in Norwich, New York is as varied in its capabilities as it is its equipment investment strategy. This dedication to growth through equipment and technology investment has led to it being recognized as one of Pharmaceutical Processing’s Facility Excellence Award winners for 2014.
Custom Processing Services has a strong track record of contract manufacturing in the pharmaceuticals marketplace. And on November 11, 2011 that legacy was strengthened with the opening of a 42,000 square foot facility dedicated to GMP processing, with two unique GMP processing stations. This commitment has led to it being recognized as one of Pharmaceutical Processing’s Facility Excellence Award winners for 2014.
The Caliber Biotherapeutics manufacturing facility in Bryan, Texas offers an interesting look at the development and integration of Plant Made Pharmaceuticals. This commitment to new and innovative drug development strategies has led to it being recognized as one of Pharmaceutical Processing’s Facility Excellence Award winners for 2014.
New development technologies, expanded contract manufacturing and service capabilities, as well as innovative equipment investment strategies highlight leading practices from the best in pharmaceutical processing comprise the 2014 Pharmaceutical Processing Facility Excellence Award winners.
In the biotechnology and pharmaceutical processing industries, maintaining diaphragm valves is considered the primary bottleneck of the maintenance process. A typical diaphragm change-out can easily take a full week of plant downtime, resulting in significant hours of lost production time.
GNC, the largest specialty retailer of nutritional supplements in the world, is respected for its focus on quality. They rely on their subsidiary, Nutra Manufacturing, to apply their “quality first” principle to manufacturing. Over the years, Nutra has turned to Symetix® for high performance optical inspection systems that verify product quality.
Barrier isolator technology is one area of pharmaceutical manufacturing where the latest and greatest technology is becoming a driver of business necessity.
One of the most cost-effective ways of dealing with severe, corrosive chemicals or process media whose purity must be maintained is to use equipment with process-specific liners.
Pharmaceutical Processing's Editor In Chief Mike Auerbach discusses current and future outsourcing trends with a select group of companies.
As we move into 2014 the global pharmaceutical market can breathe a sigh of relief that the worst seems to be behind us. The hit to the marketplace due to patent expiry reached its peak in 2012 when approximately $38 billion in revenue evaporated.
Outsourcing of biopharmaceutical manufacturing has been growing for several years, to the point where contract manufacturing has become a common strategic decision for developers, extending beyond simple non-core activities and into more high-value, technical ones that leverage offerings from contract manufacturing organizations (CMOs) that some developers do not have in-house.
Summit Custom Spray Drying produces spray dried pharmaceutical grade materials as well as flavors, fragrances, cosmetics, and nutraceutical materials. The GMP-compliant, FDA-registered facility, a wholly owned subsidiary of SummitReheis, produces powdered solid particles from solutions, slurries and emulsions, and employs a Kason vibratory screener to ensure that particle sizes meet tight tolerances.
Inadequate maintenance and monitoring programs for compendial water systems can result in chemical and/or microbial excursions that impact water quality. Total viable bacteria results associated with distribution loop sampling are not available for at least 3-5 days after collection. During this time an unacceptable increase in total viable bacteria could occur as a result of an operating excursion in a water purification unit operation.
Our annual reader survey looks at issues facing innovator companies and the CMO/CSOs that support them.